Dr. Beth P. Bell This is Me

 View all 98 references Web References

1. 1. www.idsociety.org

   www.idsociety.org/Content.aspx - [Cached]

   Published on: 8/11/2008   Last Visited: 8/17/2008

   Beth P. Bell, MD, MPH, FIDSACDC/NCIRD, Atlanta, GA

2. 2. Bottom

   www.hepatitiscontrolreport.com - [Cached]

   Published on: 5/21/2008   Last Visited: 6/4/2008

   Speaking for the CDC Hepatitis Branch, Dr. Beth Bell suggested to the Committee that "states with average annual hepatitis rates over the past 10 years that are at least 2 (or 3) times the national average (that is, states with average annual rates of 20 [or 30] /100,000) should consider implementing routine hepatitis A vaccination programs statewide."States that meet this criterion are Arizona (average rate for 1987-97 of 48 per 100,000), Alaska (45), Oregon (40), New Mexico (40), Utah (33) Washington (30), Oklahoma (24), South Dakota (24), Idaho (21), Nevada (21), and California (20).Bell said that states with lower rates (such as Texas and Florida) should consider routine vaccination in counties or regions where rates have been consistently elevated or where epidemics have occurred.Furthermore, she said, vaccination of single age cohorts, linked to school entry requirements, may be the most feasible way to accomplish routine vaccination.
   
   ACIP will reconsider the matter at its November meeting.
   ...
   The nation's shortage of intramuscular immune globulin (IMIG) may end next year, according to Dr. Beth Bell, epidemiologist at the CDC Hepatitis Branch, in a presentation before the ACIP on June 24, 1998.
   ...
   Bell said that the IMIG shortage is likely to ease next year as Centeon (which acquired the Armour operation) resumes production.Additionally, another manufacturer, Bayer, is planning to enter regular production, and the Massachusetts Laboratories expect to increase their production capacity.
   
   An estimated 275,000 2ml vials were distributed nationwide in 1997.In the six month period, June to December 1998, an estimated 200,000 2ml vials will be distributed, a sizeable increase from previous levels, Bell said.CDC has worked closely with the nation's only IMIG distributor, FFF Enterprises of Temecula, California, to locate large quantities of IMIG when needed by states and localities.According to Bell, there have been no circumstances when CDC could not locate sufficient quantities of IMIG for postexposure hepatitis A prophylaxis.In January and February 1998, the nation's IMIG supply was completely depleted.CDC recommended tetanus immune globulin as a substitute, and it was used in some cases (see HCR, Fall 1997 issue).
   
   Although the shortage of IMIG is expected to improve next year, production is still hampered by an uncertain and shrinking market, competition with other products for precursor materials, and off-label uses, Bell said.

3. 3. bestd.org

   bestd.org/STD%20News/2003.12.3 - [Cached]

   Published on: 12/31/2003   Last Visited: 7/7/2008

   "There have been overall declines - that is good," said Dr. Beth Bell, chief of the epidemiology branch of CDC's viral hepatitis division.